Endocan and BDNF levels were notably lower in individuals with clinically relevant anxiety (p = 0.047 and p = 0.016, respectively), while differences in participants with and without clinically relevant depression were not statistically significant (p = 0.061 and p = 0.474, respectively). This evidence concerns the gene BDNF and depressive symptom measurement.